Cencora to acquire Retina Consultants of America for $4.6B, ~85% ownership, accretive $0.35

Cencora, Inc.

Enterprise value of $4.6B cash; expected cash outlay ~$4.3B after physician/management rollover and fees.
Cencora will hold ~85% ownership; up to $500M contingent consideration in FY2027-2028 tied to predefined objectives.
Transaction expected ~$0.35 accretive to adjusted diluted EPS in first 12 months post-close.
RCA operates nearly 300 retina specialists across 23 states, 2M+ annual visits, 40 clinical trial sites.
Funding via cash on hand and new debt; $3.3B bridge financing obtained; fiscal 2025 guidance excludes deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.